| Ursula Gahler Iha, RPH | |
|
3260 Hospital Dr, Juneau, AK 99801-7808 | |
| (907) 796-8965 | |
| (907) 796-8443 |
| Full Name | Ursula Gahler Iha |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3260 Hospital Dr, Juneau, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104166826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 781 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ursula Gahler Iha, RPH 3260 Hospital Dr, Juneau, AK 99801-7808 Ph: (907) 796-8965 | Ursula Gahler Iha, RPH 3260 Hospital Dr, Juneau, AK 99801-7808 Ph: (907) 796-8965 |
News Archive
People with early-stage lung cancer may double their chances of surviving for longer than five years by giving up smoking, UK scientists have found.
An athletic training method shown to reduce head injuries in high school football will be rolled out in Hawaii next week through an $800,000 grant to the UMass Lowell researcher who designed the system.
A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected regulatory approval in 2011 in the United States and Europe, Human Genome Sciences/GlaxoSmithKline's Benlysta will garner sales of more than $500 million in 2018 in the systemic lupus erythematosus drug market.
› Verified 3 days ago
Brett Ryan Watson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8181 Glacier Hwy, Juneau, AK 99801 Phone: 907-789-6533 | |
Adele C. G. Davis, PHARM.D., BCACP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 Salmon Creek Ln, Juneau, AK 99801 Phone: 907-463-4031 Fax: 907-463-6658 | |
Leonard Plain, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3245 Hospital Dr, Juneau, AK 99801 Phone: 907-643-4031 | |
Andrei Dabu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8181 Glacier Hwy, Juneau, AK 99801 Phone: 907-789-6533 Fax: 907-789-6527 | |
David Alan Ferguson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3033 Vintage Ave, Juneau, AK 98801 Phone: 907-523-2060 Fax: 907-523-2019 | |
Brighton E Patch, PHARM.D RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3033 Vintage Blvd, Juneau, AK 99801 Phone: 907-523-2060 Fax: 907-523-2019 |